Johnson & Johnson has received European Commission approval for nipocalimab, marketed as IMAAVY, as an add-on therapy for ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...

State Medicaid agencies are struggling to pay for an intensive therapy for children with autism — and looming federal cuts ...

Johnson & Johnson JNJ announced that the European Commission has approved Imaavy (nipocalimab) as an add-on therapy for the ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...

Beerse: Johnson & Johnson has announced that the European Commission has approved a Marketing Authorisation for IMAAVY ...

For many today, mental health isn’t just private—it’s public, performative, and yes, profitable. Social media platforms like ...

The holidays will soon be behind us, and January and February often feel so lifeless. Sugarloaf Community Theatre offers just ...

Seven years ago, cancer patients forced to travel overseas for proton therapy were promised an Australian-based service — but ...

The world might look a little different than it did in the early 2000s — OK, a lot different — but the music that defined a ...

In a milestone moment for chronic pain management, Tonix Pharmaceuticals announced on August 15, 2025, that its novel ...

Dr Chabungbam Olivia DeviTo quote Swami Vivekananda, “Education is the process of bringing out and blossoming the talent potential in human beings.” The 'Right to Education' is a fundamental right for ...